Arkolith/Insider Trading/BIOA/Form 4

Rubin Paul D

Chief Medical OfficerBioAge Labs, Inc. (BIOA) · full profile →Form 4 · filed Dec 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$702K
Net Open-Market Flow
-$702K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2025Option exercise(M)69K$4.11$283K69K
Dec 4, 2025Sell(S)69K$10.19$702K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 4, 2025Option exercise(M)69K—$022K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001210905-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML